ibudilast
Phase 3- Indications
- ALS
Company intelligence / Profile preview
WideTrial
San Francisco, California, United Stateswidetrial.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
WideTrial operates an integrated technology/service platform that enables pharmaceutical companies to run scalable Expanded Access Programs—providing investigational therapies to patients who are ineligible for clinical trials. The company has supported major initiatives such as the NIH-funded ibudilast access program for ALS and partnered with Oncotelic/Mateon Therapeutics to provide OT‑101 to oncology patients outside of research trials. Their model generates real-world data from broader patient populations while facilitating compassionate use of experimental medicines.
- Therapeutic areas
- OtherOncologyNeurology
- Modalities
- Small moleculeRNA therapyVaccine
- Industry
- Contract Research Organization
02
Drug pipeline
1 asset03
Partnerships
National Institutes of Health/NINDS – NIH-funded ALS expanded access initiative with Mayo Clinic sitesOncotelic/Mateon Therapeutics – partnership supporting expanded access for OT‑101 in multiple cancers
Beyond the preview
Go deeper on WideTrial.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WideTrial.